Related Experiment Video
Updated: Dec 31, 2025
08:05
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
3.3K
Noncoding RNAs in Atrial Fibrillation: Current Status and Prospect.
Dongchen Zhou1, Kun Yang, Jingjing Hu
1Department of Cardiology, The First Affiliated Hospital, Medical School of Zhejiang University, Zhejiang Province, China.
Journal of Cardiovascular Pharmacology
|January 3, 2020
Summary
Noncoding RNAs are crucial in atrial fibrillation (AF) development and progression. Understanding these molecules offers new diagnostic, prognostic, and therapeutic strategies for this common heart rhythm disorder.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Genetics
Background:
- Atrial fibrillation (AF) significantly contributes to cardiovascular disease burden.
- Current AF treatments are limited by incomplete understanding of its underlying mechanisms.
- Atrial remodeling is implicated in AF, but its molecular drivers are not fully elucidated.
Purpose of the Study:
- To review the role of noncoding RNAs in atrial fibrillation pathophysiology.
- To explore the diagnostic and prognostic potential of noncoding RNAs in AF.
- To discuss noncoding RNAs as future therapeutic targets for AF.
Main Methods:
- Literature review of recent studies on noncoding RNAs and AF.
- Synthesis of evidence on microRNAs, long noncoding RNAs, and circular RNAs in AF.
- Analysis of noncoding RNA functions in atrial remodeling and AF development.
Main Results:
- Noncoding RNAs (microRNAs, lncRNAs, circRNAs) are increasingly recognized for their critical roles in AF.
- These molecules are implicated in the molecular mechanisms driving atrial remodeling in AF.
- Evidence suggests noncoding RNAs can serve as biomarkers for AF diagnosis and prognosis.
Conclusions:
- Noncoding RNAs are key players in the pathophysiology of atrial fibrillation.
- Noncoding RNAs hold significant promise as diagnostic and prognostic biomarkers for AF.
- Targeting noncoding RNAs represents a potential novel therapeutic avenue for managing AF.
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
1.5K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
01:29Disturbances in Heart Rhythm
2.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.3K
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
387
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
387
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
396
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
396